Applied Genomic Technology Capital Fund, L.P.

Applied Genomic Technology Capital Fund, L.P. is a venture capital fund operated by Flagship Pioneering, Inc. and has approximately $11.5 million in assets. The current minimum investment for Applied Genomic Technology Capital Fund, L.P. is $100000. 17 percent of the fund is owned by fund of funds. Management owns 17 percent of the fund.

Applied Genomic Technology Capital Fund, L.P. Overview

Applied Genomic Technology Capital Fund, L.P. Details

Subadviser: No Is Applied Genomic Technology Capital Fund, L.P. a subadviser

Other Investment Advisers: No other investment advisors

Solicited: No  Does Applied Genomic Technology Capital Fund, L.P. solicit investments?

Rely on Reg D Exemption: Yes  Does Applied Genomic Technology Capital Fund, L.P. have a Reg D exemption?

Audited: Yes  Does Applied Genomic Technology Capital Fund, L.P. shave audited financial statements?

Master Fund: Yes  Is Applied Genomic Technology Capital Fund, L.P. a master fund?

Feeder Fund: No  Is Applied Genomic Technology Capital Fund, L.P. a feeder fund?

GAAP: Yes  Does Applied Genomic Technology Capital Fund, L.P. use GAAP?

Beneficial Owners: 34  34 has 34 beneficial owners.

Management Ownership: 17% 

Fund of Fund Ownership: 29%  

Non-US Ownership: 2%  Non-US ownership in Applied Genomic Technology Capital Fund, L.P.

Auditor(s): Ernst & Young

Broker-Dealer(s):

Custodian(s): BNY Mellon, ,

Administrator(s):

Applied Genomic Technology Capital Fund, L.P. Charts and Graphs

Total AUM: $11.5 million

column_171} total assets are $11.5 million

Rank: 21217 out of 30967 registered private funds

Minimum Investment: $100000

Applied Genomic Technology Capital Fund, L.P. has a minimum investment of $100000.

Rank: 18656 out of 30967 registered private funds

Management Ownership: 17%

Applied Genomic Technology Capital Fund, L.P. is 17% owned by its management.

Rank: 6656 out of 30967 registered private funds